Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
CardioFocus, Inc., a medical device company dedicated to advancing pulsed field ablation (PFA) treatment for cardiac arrhythmias, announced major advancements across its PFA portfolio. OptiShot (TM) - ...
BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend ...
Background Mechanical compression from the ascending aorta on the left atrial anterior wall (LAAW) can cause low voltage ...
May 14, 2007 (Denver, CO) – Real-world results from a multicenter study have shown that pulmonary vein antrum isolation guided by intracardiac echocardiography is more likely to result in freedom from ...
DIAMOND BAR, California, March 22, 2017 /PRNewswire/. Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, ...
Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...
Johnson & Johnson MedTech’s Biosense Webster division has tallied up another regulatory clearance for its pulsed field ablation system, with a CE mark opening up access to Europe. The Varipulse ...
Please provide your email address to receive an email when new articles are posted on . AF recurrence after pulsed field ablation was comparable vs. after radiofrequency ablation. There were fewer ...
The US Food and Drug Administration has approved the Varipulse pulsed-field ablation (PFA) system for the treatment of drug-refractory paroxysmal atrial fibrillation (AF), device manufacturer Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results